seed
Stage
1
Investors
About
ViewsML uses AI-driven virtual biomarker staining to accelerate immunohistochemistry diagnostics by predicting biomarker expression at the cellular level, reducing time and cost for cancer and precision medicine research.
Explore ViewsML's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.